Journal of Inorganic Biochemistry

Aims & Scope

The Journal of Inorganic Biochemistry is an established international forum for research in all aspects of Biological Inorganic Chemistry.

Original papers of a high scientific level are published in the form of Articles (full length papers), Short Communications, Focused Reviews and Bioinorganic Methods.

Topics include: the chemistry, structure and function of metalloenzymes; the interaction of inorganic ions and molecules with proteins and nucleic acids; the synthesis and properties of coordination complexes of biological interest including both structural and functional model systems; the function of metal- containing systems in the regulation of gene expression; the role of metals in medicine; the application of spectroscopic methods to determine the structure of metallobiomolecules; the preparation and characterization of metal-based biomaterials; and related systems.

The emphasis of the Journal is on the structure and mechanism of action of metallobiomolecules.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.2
2024	3.80

SJR (SCImago Journal Rank)

Year	Value
2024	0.621

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	150

Journal Rank

Year	Value
2024	9331

Journal Citation Indicator

Year	Value
2024	2718

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Chemistry, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)

  Citation: 878

  Authors: Christian G., Stefanie, Michael A., Bernd, Haralabos, Bernhard K.

• The essential metals for humans: a brief overview

  Citation: 873

  Authors: Maria Antonietta, Jan, Guido, Serenella, Massimiliano, Valeria Marina

• Cadmium carcinogenesis in review

  Citation: 710

  Authors: Michael P

• High-valent iron in chemical and biological oxidations

  Citation: 556

  Authors: John T.

• Oxidation of nitrogen oxides by bound dioxygen in hemoproteins

  Citation: 524

  Authors: Michael P., James W.

• Approaching tumour therapy beyond platinum drugs

  Citation: 475

  Authors: A., C., J.H.M., J.H., G.

• Vanadium treatment of type 2 diabetes: A view to the future

  Citation: 467

  Authors: Katherine H., Jay, Carl, Michael C., John H., Chris

• A formula for correlating p K a values determined in D 2 O and H 2 O

  Citation: 456

  Authors: Artur, Wojciech

• Vanadium in diabetes: 100 years from Phase 0 to Phase I

  Citation: 454

  Authors: Katherine H., Chris

• DNA binding and cleavage properties of certain tetrammine ruthenium(II) complexes of modified 1,10-phenanthrolines – effect of hydrogen-bonding on DNA-binding affinity

  Citation: 445

  Authors: P, M

---